Sigma Healthcare Ltd (AU:SIG) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sigma Healthcare Ltd has reported a significant increase in financial performance, with normalised net revenue up 17.3% to $1.84 billion, driven by a new 5-year supply contract with Chemist Warehouse Group expected to generate $3 billion annually. The company has also efficiently managed a 40% increase in pharmacy wholesaling volume, showcasing strong operational execution and a positive outlook for future growth. Additionally, Sigma’s franchise brands, Amcal and Discount Drug Stores, have achieved a 13% growth in like-for-like sales, contributing to the company’s robust half-year results.
For further insights into AU:SIG stock, check out TipRanks’ Stock Analysis page.